The National Center for Advancing Translational Sciences (NCATS) has announced the following SBIR/STTR funding opportunities:
Non-Viral Technologies for in vivo Delivery of Genome Editors
These funding opportunities is to support the development and evaluation of non-viral technologies to deliver genome editors to disease relevant somatic cells and tissues in vivo. The ultimate goal of these technologies is translation into clinical trials of genome editing to treat human disease.
Please refer to the funding opportunity for details on eligibility, required registrations, application, and submission of proposals.
The Utah Innovation Center is available to support your efforts as you apply for these or other SBIR/STTR opportunities. Please contact us at email@example.com.